3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
52
Thoracic
16
Gynecologic
13
Head & Neck
10
Breast
9
Genitourinary
7
Sarcoma
2
NET
2
Endocrine
2
Dermatologic
2
Other solid neoplasm
1
CNS
1
Conditions
Glioblastoma
276
Brain Neoplasms
169
Glioma
139
Central Nervous System Neoplasms
85
Gliosarcoma
79
Astrocytoma
74
Neuroblastoma
64
Oligodendroglioma
42
Neoplasms
40
Breast Neoplasms
38
Recurrence
37
Carcinoma, Non-Small-Cell Lung
31
Medulloblastoma
27
Melanoma
26
Ovarian Neoplasms
24
Lymphoma
21
Diffuse Intrinsic Pontine Glioma
21
Sarcoma
19
Neoplasm Metastasis
19
Lung Neoplasms
18
Colorectal Neoplasms
17
Rhabdomyosarcoma
16
Osteosarcoma
16
Meningeal Carcinomatosis
15
Ependymoma
15
Pancreatic Neoplasms
14
Meningioma
14
Sarcoma, Ewing
13
Stomach Neoplasms
12
Esophageal Neoplasms
12
Interventions
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Biliary Tract Neoplasms
×
CNS
×
Clear all
NCT05094336
2026-05-28
MTAPESTRY 101
Amgen
Phase 1/2
Active not recruiting
329 enrolled